Abstract
The Dutch government introduced the CoronaMelder smartphone application for digital contact tracing (DCT) to complement manual contact tracing (MCT) by Public Health Services (PHS) during the 2020–2022 SARS-CoV-2 epidemic. Modelling studies showed great potential but empirical evidence of DCT and MCT impact is scarce. We determined reasons for testing, and mean exposure-testing intervals by reason for testing, using routine data from PHS Amsterdam (1 December 2020 to 31 May 2021) and data from two SARS-CoV-2 rapid diagnostic test accuracy studies at other PHS sites in the Netherlands (14 December 2020 to 18 June 2021). Throughout the study periods, notification of DCT-identified contacts was via PHS contact-tracers, and self-testing was not yet widely available. The most commonly reported reason for testing was having symptoms. In asymptomatic individuals, it was having been warned by an index case. Only around 2% and 2–5% of all tests took place after DCT or MCT notification, respectively. About 20–36% of those who had received a DCT or MCT notification had symptoms at the time of test request. Test positivity after a DCT notification was significantly lower, and exposure-test intervals after a DCT or MCT notification were longer, than for the above-mentioned other reasons for testing. Our data suggest that the impact of DCT and MCT on the SARS-CoV-2 epidemic in the Netherlands was limited. However, DCT impact might be enlarged if app use coverage is improved, contact-tracers are eliminated from the digital notification process to minimise delays, and DCT is combined with self-testing.
Funder
Ministerie van Volksgezondheid, Welzijn en Sport
Publisher
Public Library of Science (PLoS)
Reference35 articles.
1. Automated and partly automated contact tracing: a systematic review to inform the control of COVID-19;I Braithwaite;Lancet Digit Health,2020
2. Effectiveness of contact tracing apps for SARS-CoV-2: A rapid systematic review;K Jenniskens;BMJ Open,2021
3. Digital exposure notification tools: A global landscape analysis;C Nebeker;medRxiv,2022
4. Digitale middelen in de strijd tegen COVID-19;MEE Kretzschmar;Ned Tijdschr Geneeskd,2020